Professor Dressler Joins a New Botulinum Toxin Drug Project

Professor Dirk Dressler, Head of Movement Disorders Section at Hannover Medical School, Hannover, Germany partners with Wizmedi from Korea to develop a new botulinum toxin drug. ‘We have been involved in the development of all major botulinum toxin drugs currently available. This is project, however, is extremely exciting as it uses a novel type of botulinum toxin ‘, explains Dressler. Botulinum toxin drugs are mainly characterised by the type of botulinum toxin they use. So far, only botulinum toxin types A1 and B have been used. This project is based on botulinum toxin type A6, developed and patented by Dr Eric A Johnson and his team at the University of Madison in Wisconsin, USA. The new drug will be produced in Korea and in the USA and will be marketed globally for aesthetic and for therapeutic indications. ‘Korea is now the most active place in the world for botulinum toxin drug manufacturing. This is the place to be’.

Prof. Dirk Dressler (center, left) Dr. Eric A Johnson (center, right) managment of Wizmedi

Unsere Zertifizierer

Testimonials

Sorry, this entry is only available in Deutsch.

Erzählen Sie doch ein auch wenig von Ihren Erfahrungen mit IAB!

Get in touch with us!

Name (required)

E-Mail Address (required)

Your Message

If you send us requests via our contact form or email, your details from the contact form or email, including the contact data you have provided there, will be stored for the purpose of processing your request and in the event of follow-up questions. You are required to provide an email address to contact us. Your name is optional. Under no circumstances will we pass on this data without your consent. The legal basis for processing the data is our legitimate interest in responding to your request pursuant to Art. 6 para. 1 lit. f GDPR and, if applicable, Art. 6 para. 1 lit. b GDPR, provided that your request is aimed at concluding a contract. Your data will be deleted after final processing of your request, provided that there are no legal storage obligations to the contrary. You can object to the processing of your personal data at any time in the case of Art. 6 para. 1 lit. f GDPR.